ANAVEX LIFE SCIENCES CORP. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Anavex Life Sciences Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2015 to Q2 2024.
  • Anavex Life Sciences Corp. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.5M, a 35.9% decline year-over-year.
  • Anavex Life Sciences Corp. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $10.7M, a 44.5% decline year-over-year.
  • Anavex Life Sciences Corp. annual Share-based Payment Arrangement, Expense for 2023 was $16.4M, a 10.9% decline from 2022.
  • Anavex Life Sciences Corp. annual Share-based Payment Arrangement, Expense for 2022 was $18.4M, a 124% increase from 2021.
  • Anavex Life Sciences Corp. annual Share-based Payment Arrangement, Expense for 2021 was $8.2M, a 68.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $10.7M $2.5M -$1.4M -35.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $12.1M $2.7M -$1.3M -32.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $13.4M $2.3M -$3M -56.6% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $16.4M $3.2M -$2.86M -47.2% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-27
Q2 2023 $19.3M $3.9M -$88.6K -2.22% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $19.4M $4M -$439K -9.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $19.8M $5.3M +$1.39M +35.6% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 $18.4M $6.06M +$2.94M +94.3% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-27
Q2 2022 $15.5M $3.99M +$1.69M +73.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $13.8M $4.44M +$2.59M +140% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $11.2M $3.91M +$2.97M +316% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $8.2M $3.12M +$2.46M +372% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-27
Q2 2021 $5.74M $2.29M +$1.04M +83.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.7M $1.85M +$145K +8.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $4.55M $939K -$325K -25.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $4.88M $661K -$576K -46.6% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-28
Q2 2020 $5.45M $1.25M +$16.9K +1.37% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $5.44M $1.7M -$192K -10.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $5.63M $1.26M -$803K -38.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $6.43M $1.24M -$255K -17.1% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-28
Q2 2019 $6.69M $1.23M -$444K -26.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $7.13M $1.89M +$667K +54.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $6.46M $2.07M +$945K +84.2% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $5.52M $1.49M +$374K +33.5% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-16
Q2 2018 $5.14M $1.68M +$518K +44.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $4.63M $1.23M +$257K +26.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $4.37M $1.12M +$233K +26.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $4.14M $1.12M -$3.28M -74.6% Jul 1, 2017 Sep 30, 2017 10-K/A 2019-01-25
Q2 2017 $7.41M $1.16M +$929K +404% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $6.48M $969K +$746K +335% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $5.74M $889K +$673K +312% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 $5.06M $4.39M Jul 1, 2016 Sep 30, 2016 10-K/A 2019-01-25
Q2 2016 $230K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $223K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $216K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.